What is the 13F Pro Quality Score for DYAI?

13F Pro ranks DYADIC INTERNATIONAL INC (DYAI) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View DYAI's current score at https://13fpro.ai/research/DYAI (free sign-up required for the full ranking).

Which hedge funds own the most DYAI stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of DYAI include APIS CAPITAL ADVISORS,, VANGUARD CAPITAL MANAGEMENT, CHAPIN DAVIS,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/DYAI as soon as new 13F filings post.

Where does 13F Pro source DYAI data?

All DYADIC INTERNATIONAL INC fundamentals and ownership data come directly from SEC EDGAR. DYADIC INTERNATIONAL INC files with the SEC under CIK 1213809. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is DYAI in?

DYADIC INTERNATIONAL INC (DYAI) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is DYAI research updated on 13F Pro?

DYAI's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

DYADIC INTERNATIONAL INC(DYAI)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1213809 DYAI stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $3.5M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

DYAI Stock Analysis & AI Quality Score

AI stock analysis and institutional research for DYADIC INTERNATIONAL INC (DYAI), a Healthcare sector company. DYAI is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $3.5m in revenue. Based on the latest XBRL financial filings (Q1 2026), DYADIC INTERNATIONAL INC reports quarterly revenue of $1.1M, net income of $-2.0M, free cash flow of $-2.0M. Top institutional holders of DYAI by reported 13-F value include APIS CAPITAL ADVISORS,, VANGUARD CAPITAL MANAGEMENT, CHAPIN DAVIS,, based on the most recent SEC filings. DYAI trades on the Nasdaq exchange and files with the SEC under CIK 1213809. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DYAI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DYADIC INTERNATIONAL INC directly from SEC EDGAR.

Revenue

Q1 2026

$1.1M

Net Income

Q1 2026

$-2.0M

Free Cash Flow

Q1 2026

$-2.0M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-11.6% YoY

$3.1MFY 2025

FY22 $2.9MFY23 $2.9MFY24 $3.5MFY25 $3.1M

Net Income

-26.8% YoY

$-7.4MFY 2025

FY22 $-9.7MFY23 $-6.8MFY24 $-5.8MFY25 $-7.4M

Operating Income

-21.9% YoY

$-7.2MFY 2025

FY22 $-10.2MFY23 $-8.2MFY24 $-5.9MFY25 $-7.2M

EPS (Diluted)

-15.0% YoY

$-0.23FY 2025

FY22 —FY23 —FY24 $-0.20FY25 $-0.23

Total Assets

+0.2% YoY

$9.9MFY 2025

FY22 $13.7MFY23 $8.2MFY24 $9.9MFY25 $9.9M

Op. Cash Flow

-43.5% YoY

$-5.7MFY 2025

FY22 $-8.1MFY23 $-6.7MFY24 $-4.0MFY25 $-5.7M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Revenue	$3.1M -11.6%	$3.5M +20.6%	$2.9M -1.1%	$2.9M +21.9%	$2.4M +43.0%	$1.7M
Net Income	$-7.4M -26.8%	$-5.8M +14.5%	$-6.8M +30.2%	$-9.7M +25.5%	$-13.1M -57.3%	$-8.3M
Operating Income	$-7.2M -21.9%	$-5.9M +28.3%	$-8.2M +19.0%	$-10.2M +31.0%	$-14.7M -58.7%	$-9.3M
EPS (Diluted)	$-0.23 -15.0%	$-0.20	—	—	—	—
Total Assets	$9.9M +0.2%	$9.9M +20.8%	$8.2M -40.1%	$13.7M -35.6%	$21.3M -43.1%	$37.5M
Operating Cash Flow	$-5.7M -43.5%	$-4.0M +40.9%	$-6.7M +16.8%	$-8.1M +28.3%	$-11.3M -95.0%	$-5.8M

AI Insight: DYAI Financial Trends

Revenue remains negligible at $1M while losses persist at $2M per quarter; equity collapsed from $3M to near-zero.

• Revenue flat at $1M for past five consecutive quarters (Q3 2025–Q1 2026), showing zero growth momentum.

• Operating losses consistent at $2M per quarter across entire 8-quarter period; no path to profitability visible.

• Shareholder equity eroded from $3M in Q2 2024 to near-zero ($-0M) in Q1 2026; equity turned negative in Q2 2025.

⚠ Negative equity signals balance-sheet insolvency risk; company burning cash with no revenue traction.

⚠ Operating cash flow persistently negative at $2M per quarter; no improvement despite elapsed time.

AI Insight: DYAI Ratio Trends

DYAI remains deeply unprofitable across all profitability metrics; operating and net margins have deteriorated significantly since Q3 2024.

• Operating margin worsened from -10.3% in Q3 2024 to -171.3% in Q1 2026, signaling severe operational losses and lack of cost control.

• Net profit margin collapsed to -176.0% in Q1 2026 versus -10.4% in Q3 2024, indicating mounting net losses relative to revenue.

• ROA deteriorated to -93.4% on TTM basis (Mar 2026) from -7.5% in Q3 2024, showing persistent asset destruction.

⚠ Q3 2025 showed marginal improvement in OpMargin (-165.3%) and ROA (-67.7%) versus Q2 2025, but Q1 2026 deterioration resumes negative trend.

⚠ No ROE, ROIC, or D/E data available; leverage and return on invested capital remain unmeasured amid ongoing losses.

Get alerted when DYAI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DYADIC INTERNATIONAL INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of DYAI

APIS CAPITAL ADVISORS, LLC
$1.0M1,270,972 sh
VANGUARD CAPITAL MANAGEMENT LLC
$761.2K928,233 sh
CHAPIN DAVIS, INC.
$728.2K888,004 sh
TRUIST FINANCIAL CORP
$267.5K326,200 sh
GEODE CAPITAL MANAGEMENT, LLC
$257.1K313,508 sh
BlackRock, Inc.
$225.8K275,425 sh
VANGUARD FIDUCIARY TRUST CO
$114.4K139,478 sh
MARATHON CAPITAL MANAGEMENT
$90.2K110,000 sh
Sage Mountain Advisors LLC
$87.4K106,564 sh
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
$79.6K97,016 sh

Fund	Value	Shares
APIS CAPITAL ADVISORS, LLC	$1.0M	1,270,972
VANGUARD CAPITAL MANAGEMENT LLC	$761.2K	928,233
CHAPIN DAVIS, INC.	$728.2K	888,004
TRUIST FINANCIAL CORP	$267.5K	326,200
GEODE CAPITAL MANAGEMENT, LLC	$257.1K	313,508
BlackRock, Inc.	$225.8K	275,425
VANGUARD FIDUCIARY TRUST CO	$114.4K	139,478
MARATHON CAPITAL MANAGEMENT	$90.2K	110,000
Sage Mountain Advisors LLC	$87.4K	106,564
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	$79.6K	97,016

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put DYAI on your watchlist

Track score changes the day DYADIC INTERNATIONAL INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is DYAI a good stock to buy?

13F Pro's AI-powered analysis of DYADIC INTERNATIONAL INC (DYAI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DYAI are available on the DYAI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own DYAI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DYAI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DYADIC INTERNATIONAL INC's investment landscape.